Get the Stockscreener App
20.75
51.57%
7.06
After Hours:
21.90
1.15
+5.54%
Pulse Biosciences Inc stock is traded at $20.75, with a volume of 2.81M.
It is up +51.57% in the last 24 hours and up +41.45% over the past month.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
See More
Previous Close:
$13.69
Open:
$14.95
24h Volume:
2.81M
Relative Volume:
12.84
Market Cap:
$1.41B
Revenue:
$-9,000
Net Income/Loss:
$-68.03M
P/E Ratio:
-19.76
EPS:
-1.05
Net Cash Flow:
$-44.76M
1W Performance:
+50.04%
1M Performance:
+41.45%
6M Performance:
+35.27%
1Y Performance:
-4.77%
1-Day Range:
$14.61
$20.80
1-Week Range:
$13.44
$20.80
52-Week Range:
$12.56
$22.75
Pulse Biosciences Inc Stock (PLSE) Company Profile
Name
Pulse Biosciences Inc
Sector
Industry
Phone
510-906-4600
Address
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
20.75 | 927.74M | -9,000 | -68.03M | -44.76M | -1.05 |
|
ISRG
Intuitive Surgical Inc
|
488.15 | 169.16B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
210.02 | 58.84B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
271.63 | 38.90B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
47.30 | 38.45B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ALC
Alcon Inc
|
78.83 | 38.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Initiated | Mizuho | Outperform |
| Jul-07-25 | Initiated | Oppenheimer | Outperform |
| Jul-27-21 | Initiated | Stephens | Overweight |
| Mar-11-21 | Initiated | Maxim Group | Buy |
| Jan-26-21 | Reiterated | H.C. Wainwright | Buy |
| May-12-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-14-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-25-19 | Initiated | H.C. Wainwright | Buy |
View All
Pulse Biosciences Inc Stock (PLSE) Latest News
Precision Trading with Pulse Biosciences Inc (PLSE) Risk Zones - Stock Traders Daily
We're Not Very Worried About Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate - Yahoo Finance
Pulse Biosciences Stock Pre-Market (+5.5%): Searching for a Catalyst - Trefis
Pulse Biosciences Heart Device Data Fuels Stock SurgePulse Biosciences (NASDAQ:PLSE) - Benzinga
Top Midday Gainers - marketscreener.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Pulse Biosciences stock rises after positive cardiac catheter study data By Investing.com - Investing.com Canada
Pulse Biosciences, Inc. Announces nPulse Cardiac Catheter Study Results - TradingView
Pulse Biosciences Achieves Success in Cardiac Catheter Study - intellectia.ai
Pulse Biosciences (PLSE) Reports Promising Clinical Data from Ca - GuruFocus
Pulse Biosciences Presents Late-Breaking Data from nPulse Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium - Investing News Network
AF heart study in 150 patients reports 96% success at 1 year - stocktitan.net
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium - Yahoo Finance
Maria Sainz Joins Pulse Biosciences Board of Directors - Medical Product Outsourcing
Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026 - The Joplin Globe
Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium - BioSpace
Analyst Calls: How does TELA correlate with NasdaqPortfolio Update Summary & Stock Market Timing Techniques - baoquankhu1.vn
Pulse Biosciences' nPulse Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium - Investing News Network
150-patient AF study puts nanosecond heart ablation tech in Boston spotlight - stocktitan.net
Mizuho Initiates Coverage on Pulse Biosciences (NASDAQ:PLSE) - Defense World
Mizuho Securities Initiates Coverage on Pulse Biosciences With Outperform Rating - marketscreener.com
Mizuho initiates Pulse Biosciences stock with Outperform rating, $25 target By Investing.com - Investing.com Canada
Does Pulse Biosciences Inc. have strong fundamentalsJuly 2025 Volume & Momentum Based Trading Ideas - mfd.ru
Technical Reactions to PLSE Trends in Macro Strategies - Stock Traders Daily
Gap Down: Is Pulse Biosciences Inc exposed to currency risksJuly 2025 Weekly Recap & High Conviction Trade Alerts - baoquankhu1.vn
Day Trade: Does Assured Guaranty Ltd outperform in volatile marketsQuarterly Earnings Report & Long-Term Growth Plans - baoquankhu1.vn
Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring A 53% Upside Potential - DirectorsTalk Interviews
Aug Outlook: Is Tiziana Life Sciences Ltd likely to announce a buybackMarket Sentiment Summary & Precise Buy Zone Tips - baoquankhu1.vn
Pulse Biosciences (NASDAQ:PLSE) & Autonomix Medical (NASDAQ:AMIX) Financial Contrast - Defense World
Jobs Data: Can Pulse Biosciences Inc sustain earnings growthRecession Risk & Weekly High Return Stock Forecasts - baoquankhu1.vn
Geopolitics Watch: Should I trade or invest in Pulse Biosciences Inc2025 Market Sentiment & Smart Allocation Stock Tips - baoquankhu1.vn
How Pulse Biosciences Inc. stock responds to policy changesValue Stock Picks & Big Gains Low Budget - Bollywood Helpline
Pulse Biosciences, Inc (PLSE) Investor Outlook: Exploring A 54% Potential Upside - DirectorsTalk Interviews
Can Pulse Biosciences Inc. stock continue upward trendTrade Volume Report & Stock Timing and Entry Methods - bollywoodhelpline.com
Trading the Move, Not the Narrative: (PLSE) Edition - Stock Traders Daily
Dividend Watch: Is Pulse Biosciences Inc stock influenced by commodity pricesJuly 2025 Breakouts & AI Driven Price Forecasts - baoquankhu1.vn
Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 1.4%Here's What Happened - MarketBeat
Pulse Biosciences Nabs FDA IDE Approval for nPulse Cardiac Catheter Ablation System Study - Medical Product Outsourcing
Pulse Biosciences updates investor deck on cardiac pipeline - TipRanks
Pulse Biosciences, Inc. Updates Investor Presentation - TradingView
Earnings Miss: Is Pulse Biosciences Inc. exposed to currency risksWeekly Stock Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Analyst Calls: Is Pulse Biosciences Inc stock recession proof2025 Earnings Impact & Daily Profit Focused Screening - Bộ Nội Vụ
Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring A 51% Potential Upside - DirectorsTalk Interviews
New Cardiac Ablation Data and Board Appointment Might Change The Case For Investing In Pulse Biosciences (PLSE) - simplywall.st
How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh - Yahoo Finance
How buybacks impact Pulse Biosciences Inc. stock valueEarnings Recap Summary & Free Verified High Yield Trade Plans - ulpravda.ru
Will Pulse Biosciences Inc. stock outperform tech sector in 20252025 Geopolitical Influence & Verified Trade Idea Suggestions - ulpravda.ru
Will Pulse Biosciences Inc. (6L8) stock profit from automation wave2025 Key Highlights & Entry Point Confirmation Signals - ulpravda.ru
Pulse Biosciences appoints healthcare veteran Maria Sainz to board By Investing.com - Investing.com Nigeria
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors - 01net
Pulse Biosciences Adds Veteran Healthtech Leader to Board - TipRanks
Pulse Biosciences Inc Stock (PLSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):